Enterprise START Programme

The Enterprise START Programme is aimed at individuals who wish to develop a technology or knowledge intensive business with export potential.  it is aimed at people in a management position who have an idea for a business and who wish to develop and test the commercial vaibility of their idea.

It runs in 12 sessions over 6 weeks, outside office hours.  It is delivered by seasoned entrepreneurs with experience of starting up and developing new businesses.  Participants will learn how to develop business proposals to a point where a presentation of their business plan for a commercially viable business can be made to an enterprise support agency. The emphasis is on practicality.

Programme start dates are:
Friday 15th September, 2006: DCU, Dublin
Tuesday 10th October, 2006: Nova UCD, Belfield
Friday 3rd November, 2006: DBIC, Guinness Enterprise Centre, Dublin 2

For further information, please contact Eva Murdoch at eva.murdoch@Enterprise-ireland.com




 
 
Copyright 2007 Growcorp Group. All Rights Reserved.
Office: Growcorp Group Limited, 3015 Lake Drive, Citywest Campus, Citywest, Dublin 24 | Telephone: +353 1 4661000 | Fax: +353 1 4661002
Site developed by 4wardwebdesign
2008
Galway and Dublin. Wednesday, 3rd December, 2008: Growcorp Group, the Irish investment vehicle, will earn over Eur 7m following the acquisition this week of Irish theranoistic company Neutekbio by Danish biotechnology development company Merrion Pharmaceuticals has signed a multi-million euro deal with Novo Nordisk to develop oral diabetes products.

2008
DUBLIN, Ireland, Nov 5, 2008 an international specialty pharmaceutical company, today announced that it has been awarded the Frost & Sullivan 2008 Osteoporosis Technology Innovation of the Year Award

2008
DUBLIN, Ireland, Nov 5, 2008 an international specialty pharmaceutical company, today announced that it has been awarded the Frost & Sullivan 2008 Osteoporosis Technology Innovation of the Year Award

2008
Merrion Pharmaceuticals the TCD based Irish American company has confirmed that it has begun a joint feasibility study on oral drug delivery with Swiss based multinational Ferring Pharmaceuticals.

2007
Merrion Pharmaceuticals Plc was admitted to the IEX today and commenced
unconditional trading.........

2006
Merrion Pharmaceuticals Ltd, Dublin, announced the successful......        

Enterprise START Programme As Enterprise Ireland are anxious to..........

Merrion Pharma raises Eur 5M ahead of 2007 float Dublin drugmaker..........

Pharma Firm Merrion Hires Funding Adviser Merrion Pharmaceuticals.........

2004
Maher appointed MD at bioscience investment specialist Growcorp.........

Biopharma Firm Plans Drug Launch.........

Investing in Ireland From World Pharmaceutical Frontiers..........